English

RxElite, Inc.

EDGAR

Quarterly report (10-Q) · filed 2008-11-14

11 filing records in this dataset, filed from 2006-08-21 to 2008-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.26 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 3257718 USD Source

Operating cash flow

-1.07 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -4754061 USD Source
Operating Cash Flow: -3680235 USD Source

Cash and cash equivalents: 1.35 million USD 2008-09-30 Source
Exact value

1348216 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

10.4 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Revenue: 2811596 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 1636435 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 2999403 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 3006036 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 3257718 USD · 2008-07-01 – 2008-09-30 Source

Net income

-29.2 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Net income: -17165275 USD · 2007-01-01 – 2007-12-31 Source
Net income: -12325534 USD · 2007-01-01 – 2007-09-30 Source
Net income: -7039840 USD · 2008-01-01 – 2008-03-31 Source
Net income: -6389599 USD · 2008-04-01 – 2008-06-30 Source
Net income: -10965762 USD · 2008-07-01 – 2008-09-30 Source

Operating cash flow

-3.89 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: -13366194 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -14228360 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -2006853 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -3680235 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -2006853 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -4754061 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -3680235 USD · 2008-01-01 – 2008-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-14.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2007-12-31
Operating income: 2 of 11 periods available· newest 2007-12-31
Net income: 2 of 11 periods available· newest 2007-12-31
Operating cash flow: 2 of 11 periods available· newest 2007-12-31
Capital expenditure: 2 of 11 periods available· newest 2007-12-31
Total assets: 2 of 11 periods available· newest 2007-12-31
Total liabilities: 1 of 11 periods available· newest 2007-12-31
Current assets: 2 of 11 periods available· newest 2007-12-31
Current liabilities: 2 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-80.2%

Prior period

USD 14.17 million

2006-01-01 – 2006-12-31
Current period

USD 2.81 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

2811596 − 14171134 = -11359538 USD

14171134 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
2811596 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Year-over-year change in Revenue: -11359538 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2811596 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#8334 Input fundies:Revenue: 14171134 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#8334
The citation records this snapshot. The page link may show a newer release later.
Net income
-328.1%

Prior period

USD 7.53 million

2006-01-01 – 2006-12-31
Current period

−USD 17.17 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-17165275 − 7525831 = -24691106 USD

7525831 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-17165275 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Year-over-year change in Net income: -24691106 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -17165275 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11529 Input fundies:NetIncome: 7525831 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11529
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 9.69 million

Prior period

−USD 3.68 million

2006-01-01 – 2006-12-31
Current period

−USD 13.37 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-13366194 − -3679005 = -9687189 USD

-3679005 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-13366194 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Year-over-year change in Operating cash flow: -9687189 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13366194 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994 Input fundies:OperatingCashFlow: -3679005 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+515.1%

Prior period

USD 300,302

2006-01-01 – 2006-12-31
Current period

USD 1.85 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

1847239 − 300302 = 1546937 USD

300302 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
1847239 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Year-over-year change in Capital expenditure: 1546937 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1847239 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038 Input fundies:CapitalExpenditure: 300302 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 2.81 million 100% of revenue
Cost of revenue USD 2.67 million 95% of revenue
Operating expenses USD 16.82 million 598% of revenue
Operating income −USD 16.68 million −593% of revenue
Tax, interest and other Derived USD 484,301 17% of revenue
Net income −USD 17.17 million −611% of revenue

Cash

Operating cash flow −USD 13.37 million −475% of revenue
Capital expenditure USD 1.85 million 66% of revenue
Free cash flow Derived −USD 15.21 million −541% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Operating loss: operating costs were 130% of revenue.
2007 Operating loss: operating costs were 693% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	14171134	18398875 Derived	-4227741	-11753572 Derived	7525831	-3979307 Derived	Source 2006-01-01 – 2006-12-31: 14171134 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -4227741 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 7525831 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -3679005 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 300302 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	2811596	19492570 Derived	-16680974	484301 Derived	-17165275	-15213433 Derived	Source 2007-01-01 – 2007-12-31: 2811596 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -16680974 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -17165275 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -13366194 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 1847239 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.8M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	14171134	Revenue: 14171134 Open source
20072007-12-31	Revenue	2811596	Revenue: 2811596 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-80.2% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 14171134 Open source
20072007-12-31	Year over year	-80.2%	Revenue: 2811596 Open source Revenue: 14171134 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -593.3% 2007

Net margin -610.5% 2007

Free cash flow margin -541.1% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Operating margin	-29.8%	Operating Income: -4227741 Open source Revenue: 14171134 Open source
20072007-12-31	Operating margin	-593.3%	Operating Income: -16680974 Open source Revenue: 2811596 Open source
20062006-12-31	Net margin	53.1%	Net Income: 7525831 Open source Revenue: 14171134 Open source
20072007-12-31	Net margin	-610.5%	Net Income: -17165275 Open source Revenue: 2811596 Open source
20062006-12-31	Free cash flow margin	-28.1%	Revenue: 14171134 Open source Operating Cash Flow: -3679005 Open source Capital Expenditure: 300302 Open source
20072007-12-31	Free cash flow margin	-541.1%	Revenue: 2811596 Open source Operating Cash Flow: -13366194 Open source Capital Expenditure: 1847239 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.4M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	-3679005	Operating Cash Flow: -3679005 Open source
20072007-12-31	Operating cash flow	-13366194	Operating Cash Flow: -13366194 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.2M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	-3979307	Operating Cash Flow: -3679005 Open source Capital Expenditure: 300302 Open source
20072007-12-31	Free cash flow	-15213433	Operating Cash Flow: -13366194 Open source Capital Expenditure: 1847239 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

42.1% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Liabilities / assets	Not reported	Total Assets: 390818 Open source
20072007-12-31	Liabilities / assets	42.1%	Total Liabilities: 8959570 Open source Total Assets: 21266365 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.59× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	2.37×	Current Assets: 362092 Open source Current Liabilities: 152981 Open source
20072007-12-31	Current assets / current liabilities	2.59×	Current Assets: 18530280 Open source Current Liabilities: 7145245 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	USD 7.53 million Exact value Exact value: 7525831 USD 2006-01-01 – 2006-12-31: 7525831 USD Inspect Net Income Open source Share or cite Citation for Net Income · RxElite, Inc. · 2006-12-31 RxElite, Inc. (edgar:1346405) Net Income: 7525831 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7525831 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11529 The citation records this snapshot. The page link may show a newer release later.	−USD 3.68 million Exact value Exact value: -3679005 USD 2006-01-01 – 2006-12-31: -3679005 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RxElite, Inc. · 2006-12-31 RxElite, Inc. (edgar:1346405) Operating Cash Flow: -3679005 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3679005 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994 The citation records this snapshot. The page link may show a newer release later.	USD 300,302 Exact value Exact value: 300302 USD 2006-01-01 – 2006-12-31: 300302 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RxElite, Inc. · 2006-12-31 RxElite, Inc. (edgar:1346405) Capital Expenditure: 300302 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 300302 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038 The citation records this snapshot. The page link may show a newer release later.	−USD 3.98 million Calculation and evidence -3679005 − 300302 USD Exact free cash flow: -3979307 USD 2006-01-01 – 2006-12-31: -3679005 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 300302 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RxElite, Inc. · 2006-12-31 RxElite, Inc. (edgar:1346405) Free cash flow: -3979307 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3679005 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994 Input fundies:CapitalExpenditure: 300302 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 17.17 million Exact value Exact value: -17165275 USD 2007-01-01 – 2007-12-31: -17165275 USD Inspect Net Income Open source Share or cite Citation for Net Income · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Net Income: -17165275 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17165275 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11529 The citation records this snapshot. The page link may show a newer release later.	−USD 13.37 million Exact value Exact value: -13366194 USD 2007-01-01 – 2007-12-31: -13366194 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Operating Cash Flow: -13366194 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13366194 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994 The citation records this snapshot. The page link may show a newer release later.	USD 1.85 million Exact value Exact value: 1847239 USD 2007-01-01 – 2007-12-31: 1847239 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Capital Expenditure: 1847239 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1847239 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038 The citation records this snapshot. The page link may show a newer release later.	−USD 15.21 million Calculation and evidence -13366194 − 1847239 USD Exact free cash flow: -15213433 USD 2007-01-01 – 2007-12-31: -13366194 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1847239 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RxElite, Inc. · 2007-12-31 RxElite, Inc. (edgar:1346405) Free cash flow: -15213433 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-05T07:52:53Z Snapshot: 6fec64b2200780742709f30adfb36f29258a4588ac203042749447ae791f5d75 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1346405?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13366194 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#11994 Input fundies:CapitalExpenditure: 1847239 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1346405/0001144204-08-016438.txt#12038 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

11 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0001346405, 1346405, edgar:1346405

Also known as Southridge Technology Group, Inc.

RxElite, Inc.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation